RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Non-muscle Invasive Bladder Cancer
Related studies linked through entity extraction aliases.
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer
- Status
- UNKNOWN
- Phase
- NA
Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG
- Status
- RECRUITING
- Phase
- N/A
A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
- Status
- COMPLETED
- Phase
- PHASE1
Outpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder Cancer
- Status
- RECRUITING
- Phase
- N/A
Machine Learning-Based Prediction of BCG Response in High-Risk Non-Muscle Invasive Bladder Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE2
En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- NA
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
- Status
- TERMINATED
- Phase
- PHASE1
Clinical and Functional Consequences of Photodynamic Diagnosis (PDD) and Intravesical Instillation Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients
- Status
- RECRUITING
- Phase
- PHASE3
Omega-3 Polyunsaturated Fatty Acids and Non-Muscle Invasive Bladder Cancer
- Status
- UNKNOWN
- Phase
- NA
Low Energy Shock Wave Therapy and Non-Muscle Invasive Bladder Cancer
- Status
- UNKNOWN
- Phase
- NA
Study of Continuous APL-1202 Treatment in Subjects With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Relapsed From Intravesical Chemo/BCG Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients
- Status
- UNKNOWN
- Phase
- PHASE3